Recruiting Efficacy and Safety of Finerenone Compared to Spironolactone in Treatment of Primary Aldosteronism NCT07688928 Conditions Adrenal Gland Diseases, Adrenocortical Hyperfunction, Endocrine Hypertension, +3 more Locations Endocrine HTN Clinic — Dhaka, Bangladesh View Trial Details
Completed Effect of a Proposed Cav1.3 Inhibitor in Primary Aldosteronism NCT05686993 Conditions Adrenal Gland Diseases, Adrenocortical Hyperfunction, Endocrine Hypertension, +3 more Locations St Bartholomew's Hospital — London, United Kingdom View Trial Details
